Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous dendritic cell therapeutic vaccine for high-grade HPV-related cervical lesions
RBR-43jdmnxPhase 2Completed
- Sponsor
- Universidade de São Paulo
- Start
- Apr 2019
- Countries
- 1
01
Overview
Phase 2, open-label trial in cervical intraepithelial neoplasia (CIN) (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Clinical outcomes. Started Apr 2019; status: completed.
02
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on RBR-43jdmnx.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-43jdmnx.